| abstract |
The invention proposed 6- (2 - ((4-amino-3- (3-hydroxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin-1-yl) methyl) -3- (2-chlorobenzyl) -4 -oxo-3,4-dihydroquinazolin-5-yl) -N, N-bis (2-methoxyethyl) hex-5-ynamide in the form of a solid crystalline hydrate and in a solid crystalline anhydrous form. Also provided is a dry powder pharmaceutical composition for inhalation containing said solid form. |